These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 35112993)
1. The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature. Abdelal R; Banerjee AR; Carlberg-Racich S; Darwaza N; Ito D; Epstein J Subst Abus; 2022; 43(1):774-784. PubMed ID: 35112993 [No Abstract] [Full Text] [Related]
2. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders. Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213 [TBL] [Abstract][Full Text] [Related]
3. Real-world study of multiple naloxone administrations for opioid overdose reversal among emergency medical service providers. Abdelal R; Banerjee AR; Carlberg-Racich S; Cebollero C; Darwaza N; Kim C; Ito D; Epstein J Subst Abus; 2022; 43(1):1075-1084. PubMed ID: 35442869 [No Abstract] [Full Text] [Related]
4. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl. Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760 [TBL] [Abstract][Full Text] [Related]
5. Examination of naloxone dosing patterns for opioid overdose by emergency medical services in Kentucky during increased fentanyl use from 2018 to 2021. Rock P; Slavova S; Westgate PM; Nakamura A; Walsh SL Drug Alcohol Depend; 2024 Feb; 255():111062. PubMed ID: 38157702 [TBL] [Abstract][Full Text] [Related]
6. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study. Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372 [TBL] [Abstract][Full Text] [Related]
8. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply. Bell A; Bennett AS; Jones TS; Doe-Simkins M; Williams LD Subst Abus; 2019; 40(1):52-55. PubMed ID: 29558283 [No Abstract] [Full Text] [Related]
9. The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs. Kim HK; Connors NJ; Mazer-Amirshahi ME Expert Opin Drug Saf; 2019 Jun; 18(6):465-475. PubMed ID: 31033357 [TBL] [Abstract][Full Text] [Related]
10. EMS runs for suspected opioid overdose: implications for surveillance and prevention. Knowlton A; Weir BW; Hazzard F; Olsen Y; McWilliams J; Fields J; Gaasch W Prehosp Emerg Care; 2013; 17(3):317-29. PubMed ID: 23734988 [TBL] [Abstract][Full Text] [Related]
11. Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review. Moe J; Godwin J; Purssell R; O'Sullivan F; Hau JP; Purssell E; Curran J; Doyle-Waters MM; Brasher PMA; Buxton JA; Hohl CM CJEM; 2020 Mar; 22(2):178-186. PubMed ID: 31955714 [TBL] [Abstract][Full Text] [Related]
12. The changing epidemiology of opioid overdose in Baltimore, Maryland, 2012-2017: insights from emergency medical services. Dun C; Allen ST; Latkin C; Knowlton A; Weir BW Ann Med; 2022 Dec; 54(1):1738-1748. PubMed ID: 35775468 [TBL] [Abstract][Full Text] [Related]
13. Patient perceptions of higher-dose naloxone nasal spray for opioid overdose. Strickland JC; Marks KR; Smith KE; Ellis JD; Hobelmann JG; Huhn AS Int J Drug Policy; 2022 Aug; 106():103751. PubMed ID: 35636070 [TBL] [Abstract][Full Text] [Related]
14. Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review. Luna G; Dermid G; Unger JB Harm Reduct J; 2024 Aug; 21(1):150. PubMed ID: 39152433 [TBL] [Abstract][Full Text] [Related]
15. Degree of Bystander-Patient Relationship and Prehospital Care for Opioid Overdose. McCann MK; Jusko TA; Jones CMC; Seplaki CL; Cushman JT Prehosp Emerg Care; 2021; 25(1):82-90. PubMed ID: 32073921 [TBL] [Abstract][Full Text] [Related]
16. Association of Fentanyl Test Strip Use, Perceived Overdose Risk, and Naloxone Possession among People Who Use Drugs. Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R Subst Use Misuse; 2024; 59(2):254-257. PubMed ID: 37807227 [No Abstract] [Full Text] [Related]
17. Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement. Infante AF; Elmes AT; Gimbar RP; Messmer SE; Neeb C; Jarrett JB Int J Drug Policy; 2024 Feb; 124():104323. PubMed ID: 38232438 [TBL] [Abstract][Full Text] [Related]
18. Treatment of opioid overdose: current approaches and recent advances. Britch SC; Walsh SL Psychopharmacology (Berl); 2022 Jul; 239(7):2063-2081. PubMed ID: 35385972 [TBL] [Abstract][Full Text] [Related]
19. Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data. Mahonski SG; Leonard JB; Gatz JD; Seung H; Haas EE; Kim HK Clin Toxicol (Phila); 2020 Feb; 58(2):117-123. PubMed ID: 31092050 [No Abstract] [Full Text] [Related]
20. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review. Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]